Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
ID:
Password:
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

Agents/Distributors
 Regional Subscription Agents/Distributors
 
Current Topics in Biochemical Research   Volumes    Volume 11  Issue 2
Abstract
Inactivation of alpha-1-protease inhibitor during experimental sepsis
John A. Samis, Kenneth A. Stewart, Michael E. Nesheim, Fletcher B. Taylor Jr.
Pages: 13 - 18
Number of pages: 6
Current Topics in Biochemical Research
Volume 11  Issue 2

Copyright © 2009 Research Trends. All rights reserved

ABSTRACT
 
Compromised alpha-1-protease inhibitor regulation of elevated neutrophil elastase levels may result in coagulation factor inactivation and contribute to coagulation disorders that accompany infections. The objective of this study was to determine whether inactivation of alpha-1-protease inhibitor was temporally associated with previously reported elevated neutrophil elastase levels and coagulation factor inactivation during inflammatory stress in baboons. The temporal changes of alpha-1-protease activity, antigen, and specific activity (activity/ antigen) were measured in three cyanocephalus baboons in response to low, medium, and lethal doses of intravenously infused Escherichia coli. With increasing doses of bacteria, alpha-1-protease inhibitor activity and antigen both increased by approx 1.2- to 2.2-fold and 1.5- to 4.0-fold, respectively, during 24-53h of severe sepsis. In contrast, the inhibitor was significantly inactivated during the final cell degeneration stage (24-53h) of severe sepsis as indicated by a 30-50% decrease in its specific activity (activity/antigen) over this time period. The observed inactivation of alpha-1-protease inhibitor during severe sepsis was reconstituted upon N-chlorosuccinimide oxidation and neutrophil elastase cleavage of purified alpha-1-protease inhibitor after native polyacrylamide gel electrophoresis. In conclusion, alpha-1-protease inhibitor inactivation during severe experimental sepsis is consistent with the inhibitor’s oxidation and neutrophil elastase cleavage and is temporally associated with elevated neutrophil elastase levels and decreased coagulation factor activity. Inactivation of alpha-1-protease inhibitor may enable elevated neutrophil elastase activity to inactivate coagulation factors during severe experimental sepsis.
Buy this Article


 
search


E-Commerce
Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Login
Search Products
Browse in Alphabetical Order : Journals
Series/Books
Browse by Subject Classification : Journals
Series/Books

Miscellaneous
Ordering Information Ordering Information
Downloadable forms Downloadable Forms